Neuro Limited - Accounts to registrar (filleted) - small 18.1

Neuro Limited - Accounts to registrar (filleted) - small 18.1


PTP Accounts Production v18.1.0.976 03023596 director 1.7.18 30.6.19 30.6.19 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure030235962018-06-30030235962019-06-30030235962018-07-012019-06-30030235962017-06-30030235962017-07-012018-06-30030235962018-06-3003023596ns15:EnglandWales2018-07-012019-06-3003023596ns14:PoundSterling2018-07-012019-06-3003023596ns10:Director12018-07-012019-06-3003023596ns10:PrivateLimitedCompanyLtd2018-07-012019-06-3003023596ns10:SmallEntities2018-07-012019-06-3003023596ns10:AuditExempt-NoAccountantsReport2018-07-012019-06-3003023596ns10:SmallCompaniesRegimeForDirectorsReport2018-07-012019-06-3003023596ns10:SmallCompaniesRegimeForAccounts2018-07-012019-06-3003023596ns10:FullAccounts2018-07-012019-06-300302359612018-07-012019-06-3003023596ns10:RegisteredOffice2018-07-012019-06-3003023596ns5:CurrentFinancialInstruments2019-06-3003023596ns5:CurrentFinancialInstruments2018-06-3003023596ns5:ShareCapital2019-06-3003023596ns5:ShareCapital2018-06-3003023596ns5:RetainedEarningsAccumulatedLosses2019-06-3003023596ns5:RetainedEarningsAccumulatedLosses2018-06-3003023596ns5:IntangibleAssetsOtherThanGoodwill2018-07-012019-06-3003023596ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2018-07-012019-06-3003023596ns5:IntangibleAssetsOtherThanGoodwill2018-06-3003023596ns5:IntangibleAssetsOtherThanGoodwill2019-06-3003023596ns5:IntangibleAssetsOtherThanGoodwill2018-06-3003023596ns5:CurrentFinancialInstrumentsns5:WithinOneYear2019-06-3003023596ns5:CurrentFinancialInstrumentsns5:WithinOneYear2018-06-30


REGISTERED NUMBER: 03023596 (England and Wales)







Unaudited Financial Statements for the Year Ended 30 June 2019

for

Neuro Limited

Neuro Limited (Registered number: 03023596)






Contents of the Financial Statements
for the Year Ended 30 June 2019




Page

Company information 1

Balance sheet 2

Notes to the financial statements 4


Neuro Limited

Company Information
for the Year Ended 30 June 2019







Director: Munzer Bader





Registered office: 6 The Roughs
Northwood
Middlesex
HA6 3DF





Registered number: 03023596 (England and Wales)





Accountants: Timewise Limited t/a George & Co.
Chartered Accountants
6 The Roughs
Northwood
Middlesex
HA6 3DF

Neuro Limited (Registered number: 03023596)

Balance Sheet
30 June 2019

30.6.19 30.6.18
Notes £    £    £    £   
Fixed assets
Intangible assets 4 3,173 3,173

Current assets
Debtors 5 3,903 3,903
Cash at bank 957 957
4,860 4,860
Creditors
Amounts falling due within one year 6 66,303 66,303
Net current liabilities (61,443 ) (61,443 )
Total assets less current liabilities (58,270 ) (58,270 )

Capital and reserves
Called up share capital 285,000 285,000
Retained earnings (343,270 ) (343,270 )
Shareholders' funds (58,270 ) (58,270 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2019.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2019 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of
the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company
as at the end of each financial year and of its profit or loss for each financial year in accordance
with the requirements of Sections 394 and 395 and which otherwise comply with the requirements
of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Neuro Limited (Registered number: 03023596)

Balance Sheet - continued
30 June 2019


The financial statements have been prepared and delivered in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

In accordance with Section 444 of the Companies Act 2006, the Income statement has not been delivered.

The financial statements were approved by the director on 13 March 2020 and were signed by:





Munzer Bader - Director


Neuro Limited (Registered number: 03023596)

Notes to the Financial Statements
for the Year Ended 30 June 2019

1. Statutory information

Neuro Limited is a private company, limited by shares , registered in England and Wales. The
company's registered number and registered office address can be found on the Company
Information page.

2. Accounting policies

Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are
measured at cost less any accumulated amortisation and any accumulated impairment losses.

Development costs are being amortised evenly over their estimated useful life of nil years.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income
Statement, except to the extent that it relates to items recognised in other comprehensive income
or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have
been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed
at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods
different from those in which they are recognised in financial statements. Deferred tax is
measured using tax rates and laws that have been enacted or substantively enacted by the year
end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is
probable that they will be recovered against the reversal of deferred tax liabilities or other future
taxable profits.

3. Employees and directors

The average number of employees during the year was 1 (2018 - 1 ) .

Neuro Limited (Registered number: 03023596)

Notes to the Financial Statements - continued
for the Year Ended 30 June 2019

4. Intangible fixed assets
Other
intangible
assets
£   
Cost
At 1 July 2018
and 30 June 2019 106,712
Amortisation
At 1 July 2018
and 30 June 2019 103,539
Net book value
At 30 June 2019 3,173
At 30 June 2018 3,173

5. Debtors: amounts falling due within one year
30.6.19 30.6.18
£    £   
Other debtors 3,903 3,903

6. Creditors: amounts falling due within one year
30.6.19 30.6.18
£    £   
Trade creditors 14,184 14,184
Taxation and social security 15,425 15,425
Other creditors 36,694 36,694
66,303 66,303